THERAGENICS CORP 4
4 · THERAGENICS CORP · Filed Oct 31, 2013
Insider Transaction Report
Form 4
Small C. Russell
VP, NeedleTech Products
Transactions
- Disposition to Issuer
Common Stock
2013-10-29$2.20/sh−68,162$149,956→ 230,250 total - Disposition to Issuer
Common Stock
2013-10-29$2.20/sh−230,250$506,550→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2013-10-29$0.93/sh−34,000$31,620→ 0 totalExercise: $0.93Exp: 2019-02-26→ Common Stock (34,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2013-10-29$1.44/sh−47,000$67,680→ 0 totalExercise: $1.44Exp: 2020-02-25→ Common Stock (47,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2013-10-29$1.71/sh−58,200$99,522→ 0 totalExercise: $1.71Exp: 2021-02-25→ Common Stock (58,200 underlying)
Footnotes (6)
- [F1]Contributed to Juniper Investment Partners, LLC prior to merger at a valuation of $2.20 per share.
- [F2]Shares of common stock which were disposed of in exchange for the right to receive $2.20 per share in cash pursuant to the Agreement and Plan of Merger, dated August 2, 2013 (as it may be amended, the "Merger Agreement"), by and between Juniper Acquisition Corporation (the "Purchaser") and Theragenics Corporation (the "Company") providing for the merger of Purchaser with and into the Company (the "Merger").
- [F3]Includes shares of common stock held in 401(k) Plan
- [F4]The stock options, which provided for vesting in four equal annual installments beginning on 2-26-2010, were cancelled in exchange for the right to receive the difference between the exercise price of the option and $2.20 per share in cash pursuant to the Merger Agreement.
- [F5]The stock options, which provided for vesting in four equal annual installments beginning on 2-25-2011, were cancelled in exchange for the right to receive the difference between the exercise price of the option and $2.20 per share in cash pursuant to the Merger Agreement.
- [F6]The stock options, which provided for vesting in four equal annual installments beginning on 2-25-12, were cancelled in exchange for the right to receive the difference between the exercise price of the option and $2.20 per share in cash pursuant to the Merger Agreement.